Dr Naomi Brosnahan

Dr. Naomi Brosnahan is a researcher, dietitian, CEO and co-founder of Counterweight Limited. With a Ph.D. from the University of Glasgow, she has over 20 years experience in delivering and researching Counterweight Programmes within the NHS, research settings and private healthcare services. Dr. Brosnahan was a Research Associate working on the Diabetes Remission Clinical Trial (DiRECT), and Semaglutide Treatment Effect in People with Obesity (STEP) studies, both of which have subsequently changed the management of type 2 diabetes and provision of weight management services on a global scale. Dr Brosnahan collaborates with researchers in the UK and internationally on clinical trials addressing a range of obesity mediated medical conditions. With authorship of over 20 scientific publications, Dr Brosnahan continues to be a leader in the field of clinical nutrition and health research.